Advertisement

Life-Sciences-Asia.com
The East-West Life Sciences Web Portal
This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more
- Expres2ion & WuXi: LoI to Test Production Platform ExpreS2 (2025-04-15)
ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), today announced that ExpreS2ion and WuXi Vaccines have signed a Letter of Intent to initiate a technology evaluation of ExpreS2ion’s proprietary Drosophila S2 expressio... - Chromatin Bioscience & Astellas Sign Collaboration Agreement (2025-04-14)
Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with Astellas Pharma, a global life sciences company. Under the agreement, Chromatin Bioscience will use its proprietar... - Braskem Siam & Mitr Phol Bio Fuel: LoI for Ethanol Supply (2025-04-10)
Secure supply of bio-ethanol is a critical pillar to reach a stable and full project realization while commercially integrating Thai sectors supplying sugarcane to more sustainable chemicals Braskem, leading global biopolymer producer , today announced that Br... - Sphere Bio: Five New Distributores in APAC Region (2025-04-09)
Operational scale-up accelerates global growth strategy to increase regional access and technical support. Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today announced a significant expans... - Neurona Therapeutics Raises $102m Financing Round (2025-04-03)
> The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global Investors, and Cormorant Asset Management, follows continued positive clinical signal from Neurona�... - AbbVie Files US Complaint against Genmab & ProfoundBio (2025-03-22)
> AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle) > Genmab categorically refutes allegations and will vigorously defend the company Genmab A/S (Nasdaq: GMAB) announced today that AbbVie... - AstraZeneca to Invest $2.5b in Beijing (2025-03-21)
> AstraZeneca is establishing a new global strategic R&D centre in Beijing, its second in China and sixth worldwide > Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai AstraZeneca today announced an investment of $2.5 bi... - RegCell Secures $45.8m in Funding; Moves HQ to US (2025-03-18)
> Funding includes $8.5M from an oversubscribed seed financing with up to $37.3M in non-dilutive investment from The Japan Agency for Medical Research and Development (AMED), underscoring Japan’s commitment to breakthrough therapies > Funding will advance RegC... - [iito] Announces Major Changes in Its Social Media Strategy (2025-03-18)
> [iito] ceased all activities on Twitter/X in 2023 > All social media activities today focussed on LinkedIn > Planning for a future outside of the “big” social media platforms [iito] Business Intelligence – a Germany-based business intelligence p... - Vivesto Licenses Apealea to China’s Zhida Pharmaceutical (2025-03-18)
Vivesto AB, an oncology-focused development company, today announced it entered a licensing agreement with Zhejiang Zhida Pharmaceutical Ltd (Zhida Pharma) for the development, production and commercialization of Vivesto’s anticancer product Apealea® (paclitaxel...
Life-Sciences-Asia.com is your doorway to the East-West life sciences!
[LSA] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Asia-Pacific, Europe and North America regions.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top